Skip to content

Impact of the Introduction of a Gastro-intestinal Panel by Polymerase Chain Reaction (PCR).

Impact of the Introduction of a Gastro-intestinal Panel by PCR on the Treatment of Patients With Gastroenteritis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03551340
Enrollment
210
Registered
2018-06-11
Start date
2018-03-01
Completion date
2020-03-30
Last updated
2020-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastroenteritis

Keywords

Gastroenteritis, panel by PCR, antibiotic use

Brief summary

Evaluation of the impact of the introduction of multiplex PCR panels on the clinical management of patients with gastroenteritis at the University Hospital of Lausanne, Switzerland.

Detailed description

Gastrointestinal multiplex PCR panels have been introduced in clinical practice several years ago, but the impact on the management of patients is yet unknown. The investigators are interested to evaluate if the multiplex PCR panels introduced at the University Hospital of Lausanne in July 2017 modified the usual medical care and in particular the prescription of anti-infectious treatments. The high sensitivity of the multiplex PCR panels should allow a more precise diagnosis of the etiology of the gastrointestinal symptoms of the patients than the traditional methods of stool culture and microscopy. The investigators expect therefore to observe a modification of the proportion of patients receiving anti-infectious treatment, but it is uncertain if it will lead to an increase or a decrease in the use of antibiotics. On one hand antibiotics could be prescribed more often due to a greater and faster detection of enteropathogens. On the other hand antibiotics could be prescribed less often due to more precise diagnosis, showing that viruses and certain bacteria do not require antibiotic treatment.

Interventions

DIAGNOSTIC_TESTGastro-intestinal panel by PCR

The study will evaluate the change in medical management with the replacement of traditional stool investigations (microscopy and culture) by the new gastrointestinal multiplex PCR panels

Sponsors

University of Lausanne Hospitals
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

Ambulatory patients who consulted the University Hospital of Lausanne between July 2016 and May 2017, and were investigated by traditional methods (stool microscopy and culture). Ambulatory patients who consulted the University Hospital of Lausanne between July 2017 and May 2018 and had stool investigations by a gastro-intestinal panel.

Exclusion criteria

Patients for whom there ia record in the file that they do not accept that their data are used for research purposes.

Design outcomes

Primary

MeasureTime frameDescription
Prescription of antibioticsWithin 1 week of availability of stool resultNumber of patients receiving a prescription of antibiotics depending on the type of investigation

Secondary

MeasureTime frameDescription
Pathogens identified1 dayNumber and types of pathogens identified depending on the type of investigation
Number of PCR tests requested.1 monthNumber of patients for whom one, two or more PCR tests were requested.
Additional investigations1 weekNumber of patients who underwent additional investigations within 1 week after reception of the results of the initial investigations

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026